Management of Chronic Q Fever Infections
Management
The prognosis of Q fever endocarditis is highly variable. There had been many
reports of fatal cases. Some patients die within a few months despite
appropriate antibiotic treatment. However, most patients respond satisfactorily
to antibiotic therapy but treatment needs to be kept up for a long period or
even for life. Tetracyclines are the mainstay of
treatment, either alone or in combination with other antibiotics. There has
been controversy over the duration of antibiotic therapy; some authors suggest
that treatment should be continued indefinitely, while others suggest that
treatment should be for periods of at least 12 months, or until there is
clinical evidence of resolution of endocarditis or
the phase I CF antibodies have fallen below 200. Each patient should be treated
individually. Patients should be warned that antibiotic treatment should
continue for at east 2 years or more. Surgical replacement valves is indicated
where the valves are severely damaged. However, numerous cases of infection of
prosthetic valves have been recorded.
The majority of cases of acute Q fever do not require follow-up. They make a rapid clinical recovery with or often without tetracycline treatment. Some of the more severe cases require more careful consideration especially if complications such as myocarditis, hepatitis, encephalitis or haemolysis are seen. In these cases, as well serological testing for phase II antibodies, tests should be carried out for phase I antibodies. Rarely, the antibody persists for months without any signs of chronic infection. To date, little is known about the development of chronic Q fever following the acute attack, and it is not possible to postulate any predisposing factors which may lead to the development of chronic disease. However, f a patient suffering from a valvular abnormality of the heart develops Q fever, this is clearly an indication for thorough and probably prolonged antibiotic therapy and follow-up.